Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Total Debt (2023 - 2025)

Profound Medical has reported Total Debt over the past 3 years, most recently at $4.5 million for Q4 2025.

  • Quarterly results put Total Debt at $4.5 million for Q4 2025, down 3.48% from a year ago — trailing twelve months through Dec 2025 was $4.5 million (down 3.48% YoY), and the annual figure for FY2025 was $4.5 million, down 3.48%.
  • Total Debt for Q4 2025 was $4.5 million at Profound Medical, roughly flat from $4.5 million in the prior quarter.
  • Over the last five years, Total Debt for PROF hit a ceiling of $7.1 million in Q4 2023 and a floor of $4.5 million in Q2 2025.
  • Median Total Debt over the past 3 years was $4.5 million (2025), compared with a mean of $4.9 million.
  • Biggest five-year swings in Total Debt: crashed 34.39% in 2024 and later dropped 3.48% in 2025.
  • Profound Medical's Total Debt stood at $7.1 million in 2023, then plummeted by 34.39% to $4.7 million in 2024, then decreased by 3.48% to $4.5 million in 2025.
  • The last three reported values for Total Debt were $4.5 million (Q4 2025), $4.5 million (Q3 2025), and $4.5 million (Q2 2025) per Business Quant data.